JUAN RODRIGUEZ: Open Payments
NPI 1205031853 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,379 in 144 payments from 19 companies in 2025. Trend: 2023 $2,598 · 2024 $3,004 · 2025 $2,379
Food & beverage: $2,379
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 20 | $324 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $280 |
| Vanda Pharmaceuticals Inc. | 11 | $274 |
| ABBVIE INC. | 15 | $253 |
| Axsome Therapeutics, Inc. | 16 | $202 |
| Alkermes, Inc. | 9 | $190 |
| Lundbeck LLC | 12 | $185 |
| Corium, LLC | 4 | $98 |
| Collegium Pharmaceutical, Inc. | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
Products named: CAPLYTA, REXULTI, INVEGA SUSTENNA, VRAYLAR, Auvelity, ARISTADA, FANAPT, HETLIOZ.
Industry payments across FL — which companies pay providers there.
